ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,138Medicare Part D Prescriptions Filled, Including Refills

Rank: 375 out of 1844

$456K Total Retail Price of All Prescriptions

Rank: 434 out of 1844

488 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 488 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 488 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 6,768 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 371 328 1 1
AMLODIPINE BESYLATE 339 293 2 6
LISINOPRIL 328 290 3 4
SIMVASTATIN 315 254 4 3
PRAVASTATIN SODIUM 245 191 5 10
HYDROCHLOROTHIAZIDE 235 203 6 9
HYDROCODONE-ACETAMINOPHEN 219 145 S3 7 2
OMEPRAZOLE 210 187 8 5
WARFARIN SODIUM 202 201 9 13
FUROSEMIDE 196 169 10 7
ATENOLOL 162 141 11 17
CARVEDILOL 147 134 12 22
METFORMIN HCL ER 123 95 13 46
METOPROLOL SUCCINATE 118 96 14 14
ATORVASTATIN CALCIUM 116 109 15 12
CITALOPRAM HBR 110 82 16 19
ALLOPURINOL 108 102 17 29
LOSARTAN POTASSIUM 96 92 18 24
RANITIDINE HCL 93 77 19 38
GLIMEPIRIDE 91 73 20 35
CRESTOR 89 70 21 30
TRIAMTERENE-HCTZ 88 81 22 48
ZOLPIDEM TARTRATE 78 72 23 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 56 24 20
SPIRONOLACTONE 75 64 25 60
METOPROLOL TARTRATE 71 56 26 11
TAMSULOSIN HCL 70 66 27 27
POTASSIUM CHLORIDE 70 68 27 16
METFORMIN HCL 68 61 29 8
ACETAMINOPHEN-CODEINE 67 51 S3 30 143
ENALAPRIL MALEATE 66 42 31 69
GABAPENTIN 64 50 32 15
MIRTAZAPINE 58 42 33 49
TRAMADOL HCL 56 47 34 18
DIGOXIN 55 52 35 67
CYMBALTA 51 38 36 36
TRAZODONE HCL 50 43 37 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.